Related Experiment Videos
[Genetics of dilated cardiomyopathy]
1Max-Delbrück-Centrum für Molekulare Medizin, Humboldt-Universität zu Berlin. lthier@mdc-berlin.de
Medizinische Klinik (Munich, Germany : 1983)
|May 22, 1998
Summary
Dilated cardiomyopathy (DCM) is a heart muscle disorder with varied causes, including genetic factors. About 20-35% of DCM cases result from inherited gene defects, often autosomal dominant.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Dilated cardiomyopathy (DCM) presents with cardiac dilatation and impaired systolic function.
- Etiologies for DCM are diverse, including viral, immunological, toxic, and genetic factors.
- Genetic forms account for 20-35% of DCM cases, predominantly autosomal dominant.
Purpose:
- To review the clinical presentation and genetic basis of dilated cardiomyopathy.
- To highlight the known genetic loci and the ongoing search for causative genes.
- To discuss the rare X-linked form of DCM linked to dystrophin gene mutations.
Summary:
- DCM is characterized by enlarged ventricles and reduced pumping function, with varied clinical manifestations.
- While many DCM cases have identifiable causes, a significant portion is inherited.
- Six dominant DCM loci are known, but specific genes remain elusive; X-linked DCM involves dystrophin mutations.
Impact:
- Understanding the genetic underpinnings of DCM is crucial for diagnosis and potential therapeutic strategies.
- Identification of causative genes will improve genetic counseling and risk assessment for affected families.
- Further research into DCM genetics may reveal novel pathways for heart muscle disease treatment.